Buy thesis: undervalued despite 700% surge, $193M cash runway to 2029, epilepsy & schizophrenia pipeline catalysts. See more ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splicing modulator payloads, today announced the completion of its ...

Janus Living stands as the only pure-play senior housing REIT, offering direct SHOP exposure and unique sector positioning.

Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing neuro-ophthalmic and ophthalmic diseases with significant ...

Detailed price information for Tenax Therapeutics (TENX-Q) from The Globe and Mail including charting and trades.

New biotech stock Kardigan may reveal Wall Street’s next move ...

Welcome to Aethlon Medical's Fiscal Year-End March 31, 2026, Earnings Conference Call. My name is Jim Frakes, and I'm the ...

AI; he uses AI tools regularly and sees potential in many of those tools as useful plugins or cool new apps. But he is ...

Dave Ricks steered the 150-year-old drug giant to a $1 trillion market cap. Can he defeat pharma’s boom and bust cycle?

The products are far from a proven sleep treatment.